RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

  • Feature ArticlesFeature Articles

    Early Biosimilar Development: A Model for Expeditious Progress to a Phase 3 Trial

    This article discusses biosimilar clinical development and how companies are addressing the clinical development concerns associated with early biosimilar drug development. Introduction The introduction of biological medicines has had a significant impact on the health of patients suffering from many debilitating and life threatening diseases. Biological medicines have dramatically reduced disability for patients with inflammatory diseases, such as rheumatoid arthriti...